NeuroInDx, Inc. Launches UNIPICK+™ – Adding New Capabilities to the Universal Single Cell Collection and Tissue Microdissection Instrument
NeuroInDx, Inc. (NDX) is proud to announce the release of the latest version of the NDX Cell & Tissue Acquisition System, UNIPICK+™.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180612005054/en/
Automated UNIPICK+™ directly integrated with Olympus IX73 inverted microscope (Photo: Business Wire)
UNIPICK+™ is the latest member of the Cell & Tissue Acquisition System (CTAS) family of products built on patented capillary-based vacuum assisted technology conceived at UCLA and developed by NDX for the isolation of individual cells from cultures and tissue microdissection. The system uses a proprietary straddle to fit most commercially available inverted microscopes, allowing researchers to add single cell isolation capabilities to their lab bench at a fraction of the price of conventional systems.
The instrument can isolate cells from a variety of formats, including tissue sections, adherent cultures, cell suspensions, 3D cultures, smears, and microfluidic chips. UNIPICK+™ features new design, full digital control, and an optional automation. Among the new applications is a novel single cell adhesion assay for comparative measurements of binding strengths among various cell types or substrates. This capability expands UNIPICK+™ application from sample acquisition to single cell analysis.
UNIPICK+™ brings new automated features while remaining the simplest and most cost-efficient solution for single cell isolation and tissue microdissection. It is available as a free-standing unit that may be used with most inverted microscopes or may be directly integrated with Olympus IX73/83 microscopes. Researchers can simply use UNIPICK+™ when they need to isolate cells and then revert to their microscope for routine cell and tissue work. It only takes a few minutes to set up the system and no microscope modifications are required.
“UNIPICK+™ enhances our product line of the most versatile and cost-efficient tools for cell isolation and tissue microdissection. By designing our instruments to be compatible with common inverted microscopes, we continue to bring value added products at a fraction of the cost of other more expensive systems,” said Stan Karsten, PhD, NDX President and CEO.
About NeuroInDx, Inc.
NeuroInDx, Inc. (NDX), founded in 2006, develops instruments for cell collection and tissue microdissection for a wide range of applications in biological sciences. For more information, please visit www.NeuroInDx.com.
Stan Karsten, PhD, 424-731-7512
President and CEO
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
GenScript Biotech Announces CE-IVD for Its Neutralizing Antibody Test Kit of SARS-CoV-2 and COVID-19 Diagnostic Products26.5.2020 15:00:00 CEST | Press release
GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in vitro diagnostic (“IVD”). Among these products is the novel cPassTM – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit which detects the presence of neutralizing antibodies in an hour and does not require live biological materials or biosafety containment for testing. This is a major advance in understanding the epidemiology of the disease and if individuals have developed neutralizing antibodies that may confer immunity. cPassTM - SARS-CoV-2 Surrogate Virus Neutralization test kit The surrogate Virus Neutralization test kit is the result of an exclusive co-development agreement between Dr. Linfa Wang at Duke –NUS Medical School in Singapore, GenScript Biotech Corporation, and the Diagnostics Development Hub (DxD) at Singapore’s Agency for Science Technology and Research (A*STAR). Dr. Linfa Wang, a virologist, epidemiologist, and Director of the Emer
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining empagliflozin’s effects following an acute myocardial infarction26.5.2020 14:02:00 CEST | Press release
Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced an academic research collaboration with the Duke Clinical Research Institute (DCRI) on a new trial, EMPACT-MI (EMPAgliflozin for the prevention of Chronic heart failure and morTality after an acute Myocardial Infarction). The collaboration will investigate whether empagliflozin can improve outcomes and prevent heart failure in adults with and without diabetes who have had an acute myocardial infarction, more commonly known as a heart attack. This randomized clinical trial will be conducted, analyzed and reported in partnership with the DCRI, with Boehringer Ingelheim and Lilly providing funding. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005445/en/ EMPACT-MI will include approximately 3,300 adults across at least 16 countries who have had an acute myocardial infarction. The primary endpoint of the trial is to assess the effect of empagliflozi
Smiths Medical Announces Ventilator Training Alliance App Partnership26.5.2020 14:00:00 CEST | Press release
Smiths Medical announced today it has joined several of the world’s other ventilator manufacturers in the Ventilator Training Alliance (VTA) to support frontline medical providers access to a centralized repository of ventilator training. The content can be found in a mobile app managed by Allego. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005108/en/ Ventilator Training Alliance App (Photo: Business Wire) “Smiths Medical is proud to be a part of the VTA by providing training for our ventilators through the Allego app,” said Jeffrey Hohn, Vice President, Global Product and Commercial Excellence, Strategy and M&A at Smiths Medical. “Improving healthcare around the world is the foundation of our mission. During this critical time, we understand healthcare professionals need ventilator information quickly and the app enables the right care delivered to their patients, quickly.” The VTA app connects respiratory therapis
Panasonic and Olympian Katie Ledecky to Host Online STEAM Education Workshop to Inspire Next Generation of "Change Makers" Children26.5.2020 12:48:00 CEST | Press release
Panasonic Center Tokyo (3-5-1 Ariake, Koto-ku, Tokyo, Japan. Referred to as "PC Tokyo"), the corporate global communications hub for Panasonic, has been conducting various communication activities as a corporate pavilion through exhibitions and offline events. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005385/en/ Online workshop on STEAM Education "The power to create the future" (Graphic: Business Wire) Due to the unprecedented circumstances around the world today, people's daily lives and values have been significantly impacted. We, at Panasonic, believe a new approach blending online and offline communication activities will be an essential element for corporate pavilions now more than ever. Based on this perspective, we have decided to host an online event called "The power to create the future", on Sunday, May 31, 2020. An event dedicated to children, who we believe have the ability to become "change makers" a
Fluence Broad Spectrum LED Lighting Selected for New High-Tech Quarantine Greenhouse in the Netherlands26.5.2020 12:00:00 CEST | Press release
Fluence by OSRAM (Fluence) has been selected by Wageningen University & Research (WUR) as the lighting provider for Serre Red, the university’s new, high-tech quarantine greenhouse. Serre Red will be used for critical research on plant diseases—caused by viruses, bacteria, fungi and parasitic nematodes—including quarantine pathogens, as well as research on genetically modified organisms. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005096/en/ Construction of the Serre Red research greenhouse nears completion at Wageningen campus (April 2020, photo courtesy of Unifarm – Wageningen University & Research) Built by Bosman van Zaal, Serre Red is one of the most advanced quarantine research facilities constructed to date. It features 63 compartments, ranging from 15 to 52 square meters with individual climate control, air filtering and access locks. Extensive technical equipment has been installed in a corridor sunk below
Alpega’s Freight Exchange, Teleroute, launches an API interface and a new mobile App to help their increasing number of customers work even more efficiently26.5.2020 11:23:00 CEST | Press release
Teleroute, one of the leading freight exchanges in Europe, in its objective to continue responding to the needs of its growing number of customers, launched two major improvements to its current offering: an advanced API interface and a new version of its mobile application. Both are focused on closing a transport deal and finding new business partners more efficiently. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200526005339/en/ Teleroute, one of the leading freight exchanges in Europe launched an advanced API interface and a new version of its mobile application. (Photo: Business Wire) Today more than ever it is crucial for freight forwarders and transport companies to be able to quickly respond to the increasing demands of their clients. Teleroute’s new API interface allows companies to save a significant amount of time and avoid errors by posting their loads in the freight exchange directly from their TMS (Transport M